Pre-Application Webinar for the "PDAC Stromal Reprograming Consortium (PSRC)": RFA-CA-21-041 and RFA-CA-21-042
Notice Number:
NOT-CA-21-106

Key Dates

Release Date:

August 5, 2021

Related Announcements

RFA-CA-21-041 - Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)


RFA-CA-21-042 - Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a public pre-application teleconference on Tuesday, August 31, 2021, at 2:00-4:00 PM (ET) and on Friday, September 3, 2021, at 2:00-4:00 PM (ET) for the "PDAC Stromal Reprograming Consortium (PSRC)" Funding Opportunity Announcements (FOAs):

  • RFA-CA-21-041 - Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)
  • RFA-CA-21-042 - Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)

NCI staff members involved in managing this program will provide technical assistance to potential applicants by explaining the goals and objectives of this initiative and answering questions from attendees.

Potential applicants are encouraged to submit their questions or comments to pu5s@nih.gov and hildesheimj@mail.nih.gov in advance of the teleconference.

Registration: Potential applicants interested in participating in the teleconference should send an email to Ms. Terese Trent (tt21x@nih.gov) to obtain registration information no later than 5:00 PM (ET) on August 27, 2021.

Please include "NCI Technical Assistance Webinar for PSRC FOAs” in the subject line of the email.

Participation in this teleconference, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-21-041 or RFA-CA-21-042.

Inquiries

Please direct all inquiries to:

Peter Ujhazy, MD, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5681
Email: pu5s@nih.gov

Jeff Hildesheim, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6213
Email: hildesheimj@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices